Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.